In obesity, only a few studies have investigated the role of the type 3 ILC (ILC3), but it has been hypothesized that IL-17 and IL-22 secreted from ILC3s may favor obesity and inflammation [60]. Here, IL22 is linked to obesity due to melanocortin 4 receptor deficiency.